Anna Lok, M.D, is a professor of internal medicine and the director of clinical hepatology at the University of Michigan Medical Center. Dr. Lok graduated from the School of Medicine at the University of Hong Kong and received her training in hepatology under the late Professor Dame Sheila Sherlock at the Royal Free Hospital in London.
Dr. Lok has made seminal contributions to our understanding of the natural history of hepatitis B and the role of hepatitis B virus genotypes and variants in the outcome of chronic hepatitis B infection. She has also made important contributions to the treatment of hepatitis B. She has published more than 200 papers on viral hepatitis and liver diseases. In addition to her research contributions, Dr. Lok has also played a major role in educating the medical community as well as the lay public on hepatitis B. She is a co-author of the American Association for the Study of Liver Diseases Practice Guidelines on Management of Hepatitis B, and she served on the panel for the European Association for the Study of the Liver Consensus Recommendations on Hepatitis B. She is actively involved in many research projects on hepatitis B, hepatitis C, and liver transplantation.
During her distinguished career, she has received numerous awards for research and teaching. In 1996, Dr. Lok received the Hugh R. Butt Award for Distinguished Achievement in Clinical Research in Hepatology from the American Digestive Health Foundation. In 2002 she was awarded the University of Texas Southwestern Medical Foundation's Distinguished Visiting Professorship that honors women in science and medicine. In 2005, she received a Freedom to Discover Award from the Bristol–Myers Squibb Foundation for her contributions to infectious diseases research.
Dr. Lok served on the governing board of the American Association for the Study of Liver Diseases from 2001–2003. She is currently an Associate Editor for HEPATOLOGY, a member of the National Board of Directors of the American Liver Foundation, and a delegate of the hepatitis panel of the US–Japan Medical Science Cooperative Program.